USANA Health Sciences (USNA) Given Daily News Sentiment Score of 0.09

News headlines about USANA Health Sciences (NYSE:USNA) have trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. USANA Health Sciences earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned headlines about the company an impact score of 44.8664489527924 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

USANA Health Sciences (USNA) traded up 1.43% during trading on Friday, hitting $56.55. 84,217 shares of the company traded hands. The stock has a 50-day moving average price of $57.65 and a 200-day moving average price of $60.18. The firm has a market capitalization of $1.38 billion, a P/E ratio of 14.69 and a beta of 1.10. USANA Health Sciences has a 12-month low of $52.55 and a 12-month high of $75.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.06 by ($0.08). The company had revenue of $257.10 million during the quarter, compared to analysts’ expectations of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The company’s quarterly revenue was down .5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.07 earnings per share. Equities analysts expect that USANA Health Sciences will post $3.79 EPS for the current fiscal year.

USANA Health Sciences declared that its Board of Directors has initiated a share repurchase plan on Tuesday, July 25th that allows the company to repurchase $64.60 million in shares. This repurchase authorization allows the company to buy up to 46% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Several equities analysts recently weighed in on USNA shares. BidaskClub cut shares of USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Friday. Pivotal Research decreased their target price on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

COPYRIGHT VIOLATION WARNING: This piece was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://ledgergazette.com/2017/09/23/usana-health-sciences-usna-given-daily-news-sentiment-score-of-0-09.html.

In other USANA Health Sciences news, Director Myron W. Wentz sold 28,788 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $57.19, for a total value of $1,646,385.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Jim Brown sold 16,574 shares of the company’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $58.84, for a total value of $975,214.16. Following the completion of the transaction, the chief operating officer now owns 2,175 shares of the company’s stock, valued at approximately $127,977. The disclosure for this sale can be found here. Insiders sold a total of 386,340 shares of company stock valued at $22,535,313 in the last 90 days. Corporate insiders own 53.20% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply